The June 2 “By the Numbers” ranking the largest publicly traded healthcare providers should not have included No. 7 Cancer Genetics, Rutherford, N.J. The list should have included Amedisys, Baton Rouge, La., at No. 20. The company had more than $1.2 billion in revenue in fiscal 2013.
Corrections and clarifications
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.